Document is current
Any future updates will be listed below
-
Authors
Caubergs, Valerie https://orcid.org/0009-0001-9184-7535
Van den Broucke, Evelyne https://orcid.org/0009-0005-1425-556X
Mertens, Beatrijs https://orcid.org/0000-0002-1501-3045
Gijsen, Matthias https://orcid.org/0000-0003-1378-3772
Peetermans, Willy E. https://orcid.org/0000-0002-6974-8493
Van Wijngaerden, Eric https://orcid.org/0000-0001-8926-099X
Desmet, Stefanie https://orcid.org/0000-0002-4338-1929
Lagrou, Katrien https://orcid.org/0000-0001-8668-1350
Declercq, Peter https://orcid.org/0000-0002-6338-2355
Quintens, Charlotte https://orcid.org/0000-0002-6072-2596
Spriet, Isabel https://orcid.org/0000-0001-6342-0676
- License Information
-
More Information
Article History
Received: 15 March 2024
Accepted: 21 April 2024
First Online: 5 July 2024
Declarations
:
: I declare that the authors have no competing interests as defined by Springer, or other interests that might be perceived to influence the results and/or discussion reported in this paper. The authors have no relevant financial or non-financial interests to disclose.
: This study involves human participants and was approved by the institutional and/or national research committee (Ethics Committee Research UZ Leuven, Belgium; S61615). Pharmacist recommendations were provided to the treating physician, who finally had to decide on treatment adaptation. Patients were therefore not obliged to provide informed consent.
